论文部分内容阅读
组织型纤溶酶原激活物 (t PA)及其抑制剂 1(PAI 1)的动态平衡决定了纤溶功能 ,高血压患者多存在纤溶功能减低 ,临床常用的六类降压药物对血浆t PA和PAI 1水平有着不同的影响。
The dynamic balance of tissue-type plasminogen activator (t PA) and its inhibitor 1 (PAI 1) determines the fibrinolytic function, and fibrinolytic function is often found in patients with hypertension. The commonly used six types of antihypertensive drugs on plasma t PA and PAI 1 levels have different effects.